HGH 191AA

HGH 191AA is recombinant human growth hormone (somatropin), studied and clinically used for GH deficiency, body-composition support, and recovery-related metabolic signaling.

Profile · 01

Overview

HGH 191AA is recombinant human growth hormone (somatropin) identical to endogenous pituitary GH. Unlike many peptides in this library, somatropin has FDA-approved clinical uses and a deep human evidence base in GH deficiency and other specific conditions.

The source protocol presents a conservative once-daily subcutaneous approach for body-composition and recovery goals, while noting that higher doses increase both effect size and side-effect burden.

At a Glance

Goal
Support lean-mass retention or gain, adipose reduction, recovery, and metabolic signaling through exogenous GH
Categories
Body CompositionMetabolismRecoveryAnti-AgingPerformance
Synergistic
IGF-1 LR3 · CJC-1295 NO DAC + Ipamorelin · BPC-157 · TB-500
Profile · 02

Protocol

Suggested daily titration approach starting low and increasing by about 100 mcg weekly as tolerated.

Reconstitute
Add 3.0 mL bacteriostatic water to a 3.33 mg vial for about 1.11 mg/mL concentration
Typical daily range
200-900 mcg once daily in conservative protocols
Start
200 mcg daily
Target
400-900 mcg daily by Weeks 4-8 in conservative protocols
Frequency
Once per day (subcutaneous), commonly at bedtime
Cycle Length
8-12 weeks standard; optional extension to 16 weeks with monitoring
Timing
Evening or bedtime dosing is commonly used to mimic physiologic GH timing
Route
Subcutaneous
Cycle
8-12 weeks on, 4 weeks off

Inject once daily subcutaneously, often at bedtime, to align more closely with natural GH biology. The source also discusses advanced daily ranges above the conservative table, but those come with higher risk of fluid retention, joint symptoms, and glucose-metabolism effects.

Dose progression

Weeks 1-2
200-300 mcg (0.2-0.3 mg) · 18-27 units (0.18-0.27 mL)
Weeks 3-4
400-500 mcg (0.4-0.5 mg) · 36-45 units (0.36-0.45 mL)
Weeks 5-8
600-900 mcg (0.6-0.9 mg) · 54-81 units (0.54-0.81 mL)

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Science · 01

How HGH 191AA works.

Somatropin is recombinant human growth hormone and acts directly as exogenous GH, increasing lipolysis, protein synthesis, tissue repair signaling, and downstream IGF-1 production. Human clinical data support body-composition change and GH-deficiency treatment effects much more strongly than most peptides in this repository.

At the same time, literature in healthy adults and athletes shows that lean-mass changes do not always translate into dramatic strength or performance gains. The metabolic and fluid-balance side effects also become more relevant as doses rise.

Science · 02

Effects

Observations from clinical or preclinical literature.

Clinical studies support increased lean body mass and reduced adipose tissue in appropriate contexts
May support tissue recovery, metabolic signaling, and broader anabolic physiology
Long-term GH-deficiency literature supports durable body-composition and strength-related benefits in replacement settings
Fluid retention, edema, and joint discomfort can occur, especially at higher doses
Glucose metabolism may worsen in susceptible individuals
Injection-site irritation and lipoatrophy risk increase if site rotation is poor
Science · 03

Caution

Avoid in active malignancy or significant cancer history because GH and IGF-1 signaling can be growth-promoting
Not recommended during pregnancy or breastfeeding because non-indicated use lacks safety support
Use caution in diabetes or impaired glucose tolerance
Use caution in active intracranial lesions or other complex endocrine disorders

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Lifestyle · 01

CoFactors

Zinc
Supports GH-related signaling and immune function.
Magnesium
Supports recovery, sleep quality, and muscular function.
Vitamin D
Relevant to musculoskeletal and endocrine health.
Arginine
Sometimes discussed alongside GH-centered protocols, though this page centers on exogenous GH.
Lifestyle · 02

Life Factors

Complementary strategies for best outcomes.

Maintain adequate protein intake to support anabolic adaptation
Use resistance training and progressive overload where body composition is the main goal
Prioritize 7-9 hours of sleep because recovery quality remains central even with exogenous GH
Monitor hydration, stress, and total caloric intake to interpret body-composition changes accurately
Lifestyle · 03

Metrics

Day-to-day metrics worth tracking through the protocol.

  1. Body composition - track lean-mass and fat-mass changes over time
  2. Fluid retention and joint comfort - monitor dose-dependent side effects
  3. Sleep quality and recovery - useful for overall response tracking
  4. Fasting blood glucose - especially relevant when dose climbs
Lifestyle · 04

Labs

Baseline and periodic bloodwork to monitor systemic health during the protocol.

IGF-1
Primary downstream biomarker of GH exposure.
Fasting glucose and HbA1c
Monitor glucose-metabolism impact.
Fasting insulin
Useful for assessing insulin-resistance shifts.
Thyroid panel
GH can affect thyroid-hormone handling and recovery context.
CBC (Complete Blood Count)
General monitoring and baseline screening.
CMP (Comprehensive Metabolic Panel)
Assess broader systemic function during the protocol.
Calculators · 01

Supplies Calculator

Estimates assume the schedule defined for this peptide.

Length
Vial size
Bac. water
Syringe
Vials
0 × 3.33 mg each…
Syringes
0
Bac. water
0 mL
Swabs
02 per syringe
Calculators · 02

Dose Calculator

Dose Calculator

Vial
Bac. water
Syringe
Dose
Concentration
0mcg/mL
Volume per dose
0mL
…
Practice · 01

Preparation

Careful technique preserves potency. Solution should be clear — do not shake.

  1. Allow vial to reach room temperature for 15–20 minutes before reconstitution.
  2. Draw the chosen bacteriostatic water volume with a sterile syringe.
  3. Inject slowly down vial wall; avoid foaming.
  4. Gently swirl/roll until dissolved (do not shake).
  5. Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
  6. Use within 30 days; discard any unused solution after 30 days.
Practice · 02

Technique

General subcutaneous guidance from clinical best-practice resources.

Clean the vial stopper and injection site with alcohol and allow them to dry fully
Pinch a skinfold and insert the needle at 45-90 degrees into subcutaneous tissue
Do not aspirate for subcutaneous injections; inject slowly and steadily
Rotate sites systematically across the abdomen, thighs, and upper arms to reduce irritation and lipoatrophy
Discard used syringes immediately in a sharps container

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Practice · 03

Storage

Lyophilized
Store at room temp in dry, dark conditions; minimize moisture exposure.
Reconstituted
Refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles. Discard reconstituted vials after 30 days.

Notes

Allow vials to reach room temperature before opening to reduce condensation uptake.
Reference · 01

Notes

Use a new sterile insulin syringe for each injection and dispose of it safely
This page describes somatropin, which has real clinical uses but still carries meaningful metabolic risk outside indicated therapy
Higher doses may produce stronger cosmetic or compositional effects but also more edema, arthralgia, and glucose-related downside
Monitor labs and symptoms rather than treating GH as a harmless recovery enhancer
PepTribe is an educational platform. This information is for research and learning purposes only and is not medical advice.
Reference · 02

References

  1. NEJM
    Rudman et al., classic human growth-hormone study in older men.
    https://pubmed.ncbi.nlm.nih.gov/2355952/
  2. JCEM
    Long-term GH-deficiency follow-up and sustained body-composition outcomes.
    https://pubmed.ncbi.nlm.nih.gov/20427502/
  3. Annals of Internal Medicine
    Systematic review of GH use in healthy athletes.
    https://pubmed.ncbi.nlm.nih.gov/18316756/
  4. Pfizer label
    Genotropin prescribing information and adult starting-dose ranges.
    https://labeling.pfizer.com/ShowLabeling.aspx?id=4818
  5. CDC
    Subcutaneous injection route guidance.
    https://www.cdc.gov/vaccines/hcp/admin/downloads/YCTS-VaxAdmin-Subcut-injection.pdf
On this page